NO992153D0 - Nye konstruktur og vektorer for mÕlstyrt og induktibel ekspresjon av gener - Google Patents

Nye konstruktur og vektorer for mÕlstyrt og induktibel ekspresjon av gener

Info

Publication number
NO992153D0
NO992153D0 NO992153A NO992153A NO992153D0 NO 992153 D0 NO992153 D0 NO 992153D0 NO 992153 A NO992153 A NO 992153A NO 992153 A NO992153 A NO 992153A NO 992153 D0 NO992153 D0 NO 992153D0
Authority
NO
Norway
Prior art keywords
genes
vectors
target
driven
inducible expression
Prior art date
Application number
NO992153A
Other languages
English (en)
Norwegian (no)
Other versions
NO992153L (no
Inventor
Abderrahim Mahfoudi
Patrick Benoit
Didier Branellec
Patrice Denefle
Nicolas Duverger
Laurence Berthou
Johan Auwerx
Bart Staels
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO992153D0 publication Critical patent/NO992153D0/no
Publication of NO992153L publication Critical patent/NO992153L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO992153A 1996-11-08 1999-05-04 Nye konstruktur og vektorer for mÕlstyrt og induktibel ekspresjon av gener NO992153L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9613691A FR2755699B1 (fr) 1996-11-08 1996-11-08 Nouvelles constructions et vecteurs pour l'expression ciblee et inductible des genes
PCT/FR1997/001992 WO1998021349A1 (fr) 1996-11-08 1997-11-06 Nouvelles constructions et vecteurs pour l'expression ciblee et inductible de genes

Publications (2)

Publication Number Publication Date
NO992153D0 true NO992153D0 (no) 1999-05-04
NO992153L NO992153L (no) 1999-05-04

Family

ID=9497481

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992153A NO992153L (no) 1996-11-08 1999-05-04 Nye konstruktur og vektorer for mÕlstyrt og induktibel ekspresjon av gener

Country Status (15)

Country Link
US (1) US20020144302A1 (fr)
EP (1) EP0946740A1 (fr)
JP (1) JP2001503279A (fr)
KR (1) KR20000053163A (fr)
AU (1) AU5057898A (fr)
BR (1) BR9713981A (fr)
CA (1) CA2269864A1 (fr)
CZ (1) CZ163399A3 (fr)
FR (1) FR2755699B1 (fr)
HU (1) HUP9904235A3 (fr)
IL (1) IL129593A0 (fr)
NO (1) NO992153L (fr)
SK (1) SK61499A3 (fr)
WO (1) WO1998021349A1 (fr)
ZA (1) ZA9710114B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999005161A1 (fr) 1997-07-25 1999-02-04 Ligand Pharmaceuticals Incorporated SEQUENCES REGULATRICES DU GENE HUMAIN PPARη (RECEPTEUR GAMMA ACTIVE DE LA PROLIFERATION DES PEROXYSOMES) ET LEURS UTILISATIONS
CA2375869A1 (fr) * 1999-06-22 2000-12-28 Aventis Pharma S.A. Systeme de regulation de l'expression utilisant les recepteurs nucleaires ppar
FR2795425B1 (fr) * 1999-06-22 2003-12-05 Aventis Pharma Sa Systeme de regulation pharmacologique de l'expression utilisant les recepteurs nucleaires par et leurs ligands
EP1263978B1 (fr) * 2000-03-14 2005-12-07 Universite Pierre Et Marie Curie Promoteurs hybrides inductibles par l'inflammation, vecteurs les contenant et utilisations
FR2806418B1 (fr) * 2000-03-14 2004-07-16 Aventis Pharma Sa Promoteurs hybrides inductibles par l'inflammation, vecteurs les contenant et utilisations
EP1288303A1 (fr) * 2001-08-23 2003-03-05 Aventis Pharma S.A. Systèmes d'expression inductibles utilisant PPAR comme activateurs transcriptionnels
WO2003012113A2 (fr) * 2001-08-02 2003-02-13 Gencell S.A. Systemes d'expression inductibles utilisant des activateurs transcriptionnels ppar
US10610606B2 (en) 2018-02-01 2020-04-07 Homology Medicines, Inc. Adeno-associated virus compositions for PAH gene transfer and methods of use thereof
US11306329B2 (en) 2018-02-19 2022-04-19 City Of Hope Adeno-associated virus compositions for restoring F8 gene function and methods of use thereof
TW202140791A (zh) 2020-01-13 2021-11-01 美商霍蒙拉奇醫藥公司 治療苯酮尿症之方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0516443A1 (fr) * 1991-05-31 1992-12-02 Eli Lilly And Company Procédé et vecteurs pour essayer la régulation de la synthèse de l'apolipoprotéine AI
FR2704556B1 (fr) * 1993-04-30 1995-07-13 Rhone Poulenc Rorer Sa Virus recombinants et leur utilisation en thérapie génique.
FR2718329B1 (fr) * 1994-03-21 2002-09-20 Rhone Poulenc Rorer Sa Lapin transgénique sensibilisé aux dyslipoprotéinémies.
FR2726285B1 (fr) * 1994-10-28 1996-11-29 Centre Nat Rech Scient Adenovirus depourvus de particules contaminantes viables, preparation et utilisation

Also Published As

Publication number Publication date
FR2755699A1 (fr) 1998-05-15
HUP9904235A2 (hu) 2000-04-28
US20020144302A1 (en) 2002-10-03
CZ163399A3 (cs) 1999-08-11
ZA9710114B (en) 1998-06-08
CA2269864A1 (fr) 1998-05-22
FR2755699B1 (fr) 1998-12-18
NO992153L (no) 1999-05-04
SK61499A3 (en) 2000-02-14
AU5057898A (en) 1998-06-03
JP2001503279A (ja) 2001-03-13
HUP9904235A3 (en) 2003-03-28
WO1998021349A1 (fr) 1998-05-22
IL129593A0 (en) 2000-02-29
KR20000053163A (ko) 2000-08-25
EP0946740A1 (fr) 1999-10-06
BR9713981A (pt) 2000-05-02

Similar Documents

Publication Publication Date Title
NO992153L (no) Nye konstruktur og vektorer for mÕlstyrt og induktibel ekspresjon av gener
NO953900D0 (no) Blandinger og fremgangsmåter for utnyttelse av kondisjonelt letale gener
DE69409068T2 (de) Verkaufsstellendatenterminal und zugehöriges Druckgerät
NO983367L (no) Avisingsmateriale, fremgangsmåte for fremstilling og anvendelse av dette
NO960180D0 (no) Fremgangsmåte og etterbrennerapparatur for kontroll av meget variable strömmer
DE69421005T2 (de) Graphische Manipulation der Verschlüsselung
DK148681A (da) Forbedrede vektorer og fremgangsmaader til fremstilling af saadanne vektorer og til ekspression af klonede gener
NO971272L (no) Fremgangsmåte ved hårspleising og tilhörende hårspleiseanordning
ID15880A (id) Bentuk baru heteroaril oksazolidinon-oksazolidinon
DE69615299D1 (de) Einrichtung der Unterhaltungselektronik und Steuerungsverfahren dafür
DK0904690T3 (da) Hønsehusudstyr og fremgangsmåde til at holde fjerkræ
NO932282L (no) Oljeaktig preparat og fremgangsmaate for fremstilling av dette
NO986181D0 (no) FremgangsmÕte og anordning til fremdrift av vannfart÷yer
NO972531D0 (no) Nye membranproteiner p76 av Helicobacter pylori
NO924706D0 (no) Konstruksjon og fremgangsmaate for ekspresjon av heterologe gener i e.coli
DK0722015T3 (da) Omvikling til kabler i hængebroer og fremgangsmåde til påføring
NO972532D0 (no) Nye membranproteiner av Helicobacter pylori
DE69739936D1 (de) Genexpressionsregulator-dna, expressionskassette, expressionsvektor und transgene pflanze
NO992958L (no) Blandinger av mikroemulsjoner for kontroll av insekter
DZ2286A1 (fr) Support de catalyseur et procédé d'utilisation de celui-ci.
NO991730D0 (no) Stang og fremgangsmÕte for fremstilling av denne
DE59813942D1 (de) Anlenking von mechanischen Betätigungszügen
DE29601594U1 (de) Mantelgefäß
KR980004867U (ko) 사랑의 매
KR970003999U (ko) 헤어드라이어의 전원제어회로

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application